Clinical trials: Study the Efficacy of Epidiolex for Typical Absence Seizures

Study the Efficacy of Epidiolex for Typical Absence Seizures

Epidiolex in Typical Absence Seizures

• Completed
• Age: 6 years and older
• Phase 4

This is a Pilot study, open-label study consisting of a screening period of up to 4 weeks, a 4-week dose-titration treatment period to dose of up to 20 mg/kg/day BID of CBD (Epidiolex), and a 30 day safety follow-up period…

Trial name

NCT04899050

Testing

Cannabidiol (Epidiolex)

Where

United States

Volunteers

14 people, healthy volunteers welcome

Sponsor

University of South Florida